1.
2.
Indian J Endocrinol Metab
; 21(1): 249-250, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28217528
RESUMO
Worsening of glycemic control in type 2 Diabetes mellitus occur on account of declining beta cell function. This calls for up titration of the chosen drug, addition of another agent with complementary action and eventually insulin usually after 2 or three OADs. Introduction of insulin has many issues which include parenteral route of administration, cost and enhancement of hypoglycemic tendency. We propose the addition of another OAD in lieu of insulin in whom glycemic control can be achieved equally well without insulin.
3.
4.
J Assoc Physicians India
; 63(12): 95, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27666920
Assuntos
Diabetes Mellitus/tratamento farmacológico , Hipertrigliceridemia/tratamento farmacológico , Hipoglicemia/induzido quimicamente , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Fenilpropionatos/uso terapêutico , Pirróis/uso terapêutico , Glicemia/metabolismo , Interações Medicamentosas , Feminino , Humanos , Pessoa de Meia-Idade , PPAR alfa/agonistas , PPAR gama/agonistas
5.
6.